BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Immunol. Nov 27, 2015; 5(3): 142-151
Published online Nov 27, 2015. doi: 10.5411/wji.v5.i3.142
Helicobacter pylori vs immune system or antibiotics
David Stubljar, Miha Skvarc
David Stubljar, Miha Skvarc, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia
Author contributions: Stubljar D designed and wrote the manuscript; Skvarc M was involved in revising the manuscript critically and gave final approval of the manuscript to be published.
Conflict-of-interest statement: Authors declare no conflict of interest.
Correspondence to: David Stubljar, BSc, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Zaloska 4, 1000 Ljubljana, Slovenia. d.stubljar@gmail.com
Telephone: +386-15-437494 Fax: +386-15-437485
Received: April 28, 2015
Peer-review started: April 29, 2015
First decision: June 3, 2015
Revised: June 18, 2015
Accepted: July 24, 2015
Article in press: July 27, 2015
Published online: November 27, 2015
Processing time: 213 Days and 14.2 Hours
Core Tip

Core tip: Combination of Helicobacter pylori (H. pylori) and host-associated risk factors do not always allow evaluation of gastric carcinoma. We have learnt that the assessment of patients with H. pylori infection and its strain is very important and concluded that eradication of bacteria has essential meaning. We recommend that not only screening for H. pylori also the strain determination should have some diagnostic value, especially in the patients who already developed gastritis. Furthermore, for such patients assessment of disease progression could be followed by polymorphism determination. Conclusions indicate that host cytokine genotypes, host immune response, as well as H. pylori strains could be important for greater risk for developing gastric cancer.